NOV (NYSE: NOV) legal chief exercises options and sells 70K shares

Rhea-AI Filing Summary

NOV Inc. senior vice president and general counsel Craig L. Weinstock reported option exercises and share sales. On February 23, 2026, he exercised non-qualified stock options for 20,000 and 30,000 shares of common stock at an exercise price of $15.00 per share. The resulting 50,000 shares of common stock were then partially sold in open-market transactions totaling 70,000 shares at average prices between $19.93 and $20.37, as detailed in the footnotes. After these transactions, Weinstock directly owned 256,319 shares of NOV common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weinstock Craig L.

(Last) (First) (Middle)

10353 RICHMOND AVE.

(Street)

HOUSTON TX 77042

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOV Inc. [ NOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP. & Gen. Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		M		20,000	A	$15	296,319	D
Common Stock	02/23/2026		M		30,000	A	$15	326,319	D
Common Stock	02/23/2026		S		20,000	D	$20.3221(1)	306,319	D
Common Stock	02/23/2026		S		30,000	D	$20.0044(2)	276,319	D
Common Stock	02/23/2026		S		10,495	D	$19.94(3)	265,824	D
Common Stock	02/23/2026		S		9,505	D	$19.945	256,319	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$15	02/23/2026		M			20,000	(4)	02/23/2031	Common Stock	20,000	$0.00	51,178	D
Non-Qualified Stock Option (right to buy)	$15	02/23/2026		M			30,000	(4)	02/23/2031	Common Stock	30,000	$0.00	21,178	D

Explanation of Responses:

1. The price reported in column 4 is the average price. These shares were sold in multiple transactions. The prices for these shares ranged from $20.20 to $20.37. The reporting person undertakes to provide to NOV Inc., any securityholder of NOV Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth within this footnote (1) to this Form 4.

2. The price reported in column 4 is the average price. These shares were sold in multiple transactions. The prices for these shares ranged from $20.00 to $20.005. The reporting person undertakes to provide to NOV Inc., any securityholder of NOV Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth within this footnote (2) to this Form 4.

3. The price reported in column 4 is the average price. These shares were sold in multiple transactions. The prices for these shares ranged from $19.93 to $19.945. The reporting person undertakes to provide to NOV Inc., any securityholder of NOV Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth within this footnote (3) to this Form 4.

4. The option, representing a right to purchase a total of 71,178 shares, became exercisable in three equal installments beginning on February 22, 2022, which was the first anniversday of the date on which the option was granted.

	By: Peter F. Vranderic For: Craig L. Weinstock	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did NOV (NOV) report for Craig L. Weinstock?

Craig L. Weinstock exercised stock options and sold shares of NOV common stock. He converted 50,000 options at $15.00 per share into common stock, then sold 70,000 shares in open-market transactions at average prices around $20 per share.

How many NOV (NOV) shares did Craig L. Weinstock sell in this Form 4?

Craig L. Weinstock sold a total of 70,000 NOV common shares. The reported sales occurred in multiple open-market trades on February 23, 2026, at average prices ranging from $19.93 to $20.37, as noted in the transaction footnotes.

At what prices were the NOV (NOV) shares sold by Craig L. Weinstock?

The NOV shares were sold at volume-weighted average prices between $19.93 and $20.37. Footnotes explain that each reported price reflects an average for multiple trades, with detailed per-trade prices available upon request from NOV or the reporting person.

How many NOV (NOV) shares does Craig L. Weinstock own after these transactions?

After completing the option exercises and subsequent sales, Craig L. Weinstock directly holds 256,319 NOV common shares. This post-transaction balance reflects his remaining direct ownership as of the reported date after selling 70,000 shares in open-market transactions.

What stock options did Craig L. Weinstock exercise in NOV (NOV)?

He exercised non-qualified stock options for 20,000 and 30,000 NOV shares at an exercise price of $15.00 per share. A footnote states the option covered 71,178 shares and became exercisable in three equal installments beginning on February 22, 2022.

What is Craig L. Weinstock’s role at NOV (NOV) in this Form 4?

Craig L. Weinstock is identified as an officer of NOV, serving as senior vice president and general counsel. The Form 4 reports his personal option exercises and subsequent open-market sales of NOV common stock on February 23, 2026.